VC-backed ALX Oncology goes public
Burlingame, California-based ALX Oncology Holdings Inc, a immuno-oncology company, has raised $161.5 million for its IPO after pricing its 8.5 million shares at $19 per share.
Burlingame, California-based ALX Oncology Holdings Inc, a immuno-oncology company, has raised $161.5 million for its IPO after pricing its 8.5 million shares at $19 per share.
Copyright PEI Media
Not for publication, email or dissemination